Table 4 Relationship between MEG3 rs3087918 and clinical characteristics of cases

  > 49/<=49

102/69

120/87

28/19

148/106

 OR(95%CI)

1.00 (reference)

0.93 (0.62–1.408)

1.00 (0.52–1.95)

0.94 (0.64–1.40)

P-value

0.742

0.993

0.777

  > =24/< 24

37/134

60/147

12/35

72/182

 OR(95%CI)

1.00 (reference)

1.48 (0.92–2.37)

1.24 (0.59–2.63)

1.43 (0.91–2.26)

P-value

0.104

0.571

0.120

 yes/no

114/57

128/79

29/18

157/97

 OR(95%CI)

1.00 (reference)

0.81 (0.53–1.24)

0.81 (0.42–1.59)

0.81 (0.54–1.21)

P-value

0.330

0.526

0.307

  > 2/<=2

85/86

107/100

31/16

138/116

 OR(95%CI)

1.00 (reference)

1.08 (0.72–1.62)

1.96 (1.01–3.92)

1.20 (0.82–1.73)

P-value

0.701

0.050

0.350

 Positive/negtive

93/78

104/103

24/23

128/126

 OR(95%CI)

1.00 (reference)

0.85 (0.56–1.27)

0.88 (0.46–1.68)

0.85 (0.58–1.26)

P-value

0.422

0.686

0.419

 III-IV/I-II

51/120

59/148

16/31

75/179

 OR(95%CI)

1.00 (reference)

0.94 (0.60–1.47)

1.21 (0.60–2.39)

0.99 (0.65–1.51)

P-value

0.778

0.579

0.948

 Positive/negtive

115/56

138/69

33/14

171/83

 OR(95%CI)

1.00 (reference)

0.97 (0.63–1.50)

1.15 (0.58–2.37)

1.00 (0.66–1.51)

P-value

0.904

0.700

0.988

 Positive/negtive

94/77

112/95

33/14

145/109

 OR(95%CI)

1.00 (reference)

0.97 (0.64–1.45)

1.93 (0.98–3.97)

1.09 (0.74–1.61)

P-value

0.867

0.063

0.666

 Positive/negtive

62/109

90/117

27/20

117/137

 OR(95%CI)

1.00 (reference)

1.35 (0.89–2.05)

2.37 (1.24–4.63)

1.50 (1.01–2.24)

P-value

0.155

0.01*

0.045*